Stem Cell Patentability: Legal Challenges
Trends in Intellectual Property Research · 2024
DOI: 10.69971/tipr.2.1.2024.19 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Intellectual Property Research, 2024. Verfasst von Saba Riaz und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Stem cells are versatile cells capable of self-renewal and differentiation into different specialized cell types. Their immense potential has led to a surge in research and practical applications medicine. Patentability of the stem cells has been a subject of controversy, with concerns that restrictions on access to crucial technologies could hinder the translation of research into practical medical applications. It is a promising field that's rapidly advancing and has the potential to revolutionize modern medicine. The patentability of stem cells faces several legal challenges, including ethical, moral, and religious concerns, as well as difficulties in obtaining a patent license. Patent protection is crucial for driving innovation and commercial success in regenerative medicine and life sciences. This article examines the patentability restrictions and specific challenges associated with human stem cell patents in Europe and the United States.
Zitieren
APA
Riaz, S., Sadiqa, A., Zara, R., Hassan, M., Hussain, I., Adem, S., & Rawat, R. (2024). Stem Cell Patentability: Legal Challenges. Trends in Intellectual Property Research. https://doi.org/10.69971/tipr.2.1.2024.19
Vancouver
Riaz S, Sadiqa A, Zara R, Hassan M, Hussain I, Adem S, et al. Stem Cell Patentability: Legal Challenges. Trends in Intellectual Property Research. 2024. doi:10.69971/tipr.2.1.2024.19
BibTeX
@article{Riaz2024,
author = {Riaz, Saba and Sadiqa, Ayesha and Zara, Rabia and Hassan, Mudassir and Hussain, Ijaz and Adem, Sevki and Rawat, Ravi},
title = {Stem Cell Patentability: Legal Challenges},
journal = {Trends in Intellectual Property Research},
year = {2024},
doi = {10.69971/tipr.2.1.2024.19}
}
EUVIMED